Author:
Kikunaga Kaori, ,Ishikura Kenji,Terano Chikako,Sato Mai,Komaki Fumiyo,Hamasaki Yuko,Sasaki Satoshi,Iijima Kazumoto,Yoshikawa Norishige,Nakanishi Koichi,Nakazato Hitoshi,Matsuyama Takeshi,Ando Takashi,Ito Shuichi,Honda Masataka
Funder
Asahi Kasei Pharma Corporation, Astellas Pharma, Fuso Pharmaceutical Industries,Ltd, JMS Co., Ltd., Novartis Pharma K.K., Zenyaku Kogyo Co., Ltd
Publisher
Springer Science and Business Media LLC
Subject
Physiology (medical),Nephrology,Physiology
Reference28 articles.
1. Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet. 2003;362:629–39.
2. van Husen M, Kemper MJ. New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome. Pediatr Nephrol. 2011;26:881–92.
3. Kengne-Wafo S, Massella L, Diomedi-Camassei F, Gianviti A, Vivarelli M, Greco M, Stringini GR, Emma F. Risk factors for cyclosporin A nephrotoxicity in children with steroid-dependant nephrotic syndrome. Clin J Am Soc Nephrol. 2009;4:1409–16.
4. Pravitsitthikul N, Willis NS, Hodson EM, Craig JC. Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children. Cochrane Database Syst Rev. 2013;10:CD002290.
5. Warady BA, Chadha V. Chronic kidney disease in children: the global perspective. Pediatr Nephrol. 2007;22:1999–2009.
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献